Paying for private treatment may widen a person’s options. It does not, by itself, establish better clinical recovery. That comparison needs evidence about who was treated, what was measured, and what happened afterward. England’s NHS Talking Therapies reports offer a useful starting point: not a score private clinics should automatically beat, but a demonstration of what transparent reporting contains.
Key findings
710,950: completed courses in NHS Talking Therapies in 2025/26, compared with 670,419 in 2024/25.
50.1% versus 50.5%: the respective program-defined recovery rates.
8.8: average sessions per completed course in 2025/26.
19.3 million: appointments recorded in 2025/26, 4.5% above the previous year.
These measures concern England’s program and defined referral groups. They are not rates among everyone referred, unique-person counts in every case, or long-term recovery after discharge. [1] [2]
More activity and a similar recovery rate
| Measure | 2024/25 | 2025/26 |
|---|---|---|
| Completed courses | 670,419 | 710,950 |
| Program-defined recovery | 50.5% | 50.1% |
| Average sessions per completed course | 8.4 | 8.8 |
The recovery-rate difference is 0.4 percentage points. It does not establish why the rate changed or what would happen to the same patients in a private clinic. Sources: NHS annual reports. [1] [2]
The measures tell different parts of the service story. More appointments describe activity. Completed courses describe a defined stage of participation. Recovery describes a specified symptom threshold among eligible referrals. None should silently replace the others.
The 2025/26 report also recorded recovery of 53.1% among referrals taking up employment support alongside therapy versus 50.1% overall. This is not a randomized effect estimate: people receiving that support may differ from other referrals. [1]
The first comparison is between definitions
A private program might report a higher percentage and still not be measuring the same outcome. One figure could represent satisfaction at discharge, another symptom change, and another no longer crossing a questionnaire threshold. They cannot be ranked simply because each is written as a percentage.
NHS recovery concerns eligible referrals moving below relevant thresholds at treatment completion. It is not a declaration that no difficulties remain or that improvement persisted for a year. A result can be meaningful while still answering a limited question.
Before comparing providers, ask what counted as success and who entered the calculation. A result among all eligible completers differs from a result among a selected group answering a voluntary follow-up survey.
Who is treated can change the result
Patient populations may differ in diagnosis, symptom severity, physical health, previous treatment, and co-occurring conditions. A service taking more complex referrals could show a lower raw recovery rate even when it provides appropriate care.
The reverse is also possible. A high rate in a carefully selected population may not apply to someone with a different clinical profile. A fair comparison needs more than a broad condition label.
Public reporting is valuable because it exposes the definition, scale, and period to scrutiny. That does not make the public service the correct clinical comparator for every private setting. Residential and outpatient pathways may serve substantially different needs.
What a fair comparison would require
| Area | Required information | Misleading shortcut |
|---|---|---|
| Patients | Diagnosis, severity, prior care, and co-occurring needs | Assume all cases are equivalent |
| Eligibility | Who could enter and who was excluded | Compare all admissions with selected completers |
| Outcome | Measure, threshold, and timing | Compare satisfaction with clinical recovery |
| Follow-up | Eligible, responding, and missing participants | Assume missing people recovered |
| Treatment | Content and concurrent care | Assign every later improvement to one program |
| Cost | What the fee and follow-up package include | Compare unlike weekly prices |
This is a proposed comparison framework, not a provider audit or a claim that a particular clinic has better or worse results. It applies to THE BALANCE as well.
Access, experience, and outcomes each have value
Privacy, clinician availability, accommodation, language, and practical fit can legitimately influence a family’s decision. They describe the experience and delivery of care. They do not automatically establish an incremental clinical benefit.
A private provider should explain both kinds of value clearly. A feature can be worthwhile without being promoted as proof that patients recover more often. A patient may reasonably prefer one setting while recognizing that no direct superiority study exists.
Recognizing that limit is not the same as saying private care is ineffective. It means the claim should match the evidence: a description of the service, research supporting specific interventions, or direct evaluation of the program.
Long-term recovery needs later observations
A final-session score answers how someone was doing at that time. Follow-up asks whether gains persisted after ordinary life resumed. It needs an explicit schedule and a clear account of how many people could be reached.
Someone may receive medication, psychotherapy, or other support after the initial program. That additional care can matter to the outcome. The first provider should not automatically claim the entire later improvement.
Missing follow-up remains unknown. It should neither be assumed to represent failure nor silently excluded from the account of who was treated. A transparent report gives enough information to understand how incomplete observation limits the conclusion.
For affluent families, relevance is more useful than a league table
Available choice can make comparison more complicated. The highest published rate may come from a population least like the person considering care. The relevant question is which pathway can appropriately assess and address their needs.
For an internationally mobile family, that includes continuity after discharge. Who coordinates the clinical history, and has the receiving professional accepted the handover? A recommendation to seek local follow-up is not the same as a confirmed arrangement.
The comparison should also explain language, communication, and practical responsibilities without assuming that more countries or clinicians necessarily create better or worse care. These are details to verify in the proposed pathway.
The correct comparator follows the clinical question
A residential program should not borrow an outpatient psychotherapy rate as a simplistic benchmark. The setting may be chosen for different needs. Similarly, a result from a medication trial does not establish the performance of an entire multimodal package.
A useful study would define what alternatives were realistic for a comparable patient group. It would measure outcomes consistently, account for starting differences, and make uncertainty visible. When such data are absent, the gap should remain explicit rather than be filled with marketing arithmetic.
The article contains no such matched public-private dataset. It shows why that evidence would be needed, not which side would win.
What to ask during an admissions conversation
Ask for the latest outcome report, its definitions, and the population represented. Which findings concern the complete program rather than one therapy? Were early departures included? What was measured after discharge, and how many people participated?
Then connect the report to the proposed plan. Which needs does the clinician expect to address, and how will progress be reviewed? What changes if the first approach is insufficient? A useful answer should be specific without promising a guaranteed result.
Finally, separate comparative evidence from preference. A service can be a good fit without proof of universal superiority. Families should not have to choose between practical suitability and honest disclosure about what remains unknown.
Reporting gaps are not automatic evidence of poor care
A provider-disclosure audit would need a defined sample, consistent criteria, and an opportunity to correct factual errors. Absence of public results should be reported as a transparency gap, not automatically as clinical failure.
The same caution applies to favorable publicity. Testimonials, awards, and polished presentation do not supply the missing denominator or follow-up. They answer different questions and should not be used to imply a clinical comparison that was never conducted.
What the numbers cannot tell us
The NHS figures do not prove private care is better, worse, or equivalent. The employment-support difference is not a causal estimate. The annual recovery percentage concerns a defined completion measure, not every referral or sustained recovery over time.
The bottom line
Demand a comparable denominator before accepting a superior percentage. Money can buy options and preferred features. Whether it buys better recovery remains a clinical research question, not a conclusion established by the fee or the setting.
For journalists
Key comparison: more completed NHS courses in 2025/26 alongside a recovery rate of 50.1%, compared with 50.5% the previous year.
Important caveat: these are public program measures, not a matched comparison with private treatment.
Suggested attribution: THE BALANCE analysis of published outcome-reporting standards and NHS Talking Therapies data.
Methodology and sources
This narrative analysis preserves annual program definitions and periods. It calculates the 0.4-percentage-point difference without assigning a cause. No provider score, comparative treatment effect, or private-patient analysis was produced.


